Skip to content
  • LinkedIn

The Business of Biofabrication

  • News
  • Perspectives
  • Learn

Pharma

  • Organovo Sells FXR Drug Program to Eli Lilly in Strategic Deal to Advance IBD Therapies
    April 3, 2025

    Organovo Sells FXR Drug Program to Eli Lilly in Strategic Deal to Advance IBD Therapies

    R.D. Solorzano
  • Carcinotech’s 3D-Printed Tumor Models: A New Possibility in Cancer Research
    September 3, 2024

    Carcinotech’s 3D-Printed Tumor Models: A New Possibility in Cancer Research

    R.D. Solorzano
  • The way to make money in pharma with bioprinting?…Develop the drugs
    September 7, 2023

    The way to make money in pharma with bioprinting?…Develop the drugs

    R.D. Solorzano
Previous Page
1 2

Archives

To make sense of, stay update on, and learn about
the business of biofabrication

Subscribe

2024 All Rights Reserved

  • Subscribe Subscribed
    • The Business of Biofabrication
    • Already have a WordPress.com account? Log in now.
    • The Business of Biofabrication
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar